AbbVie Stock Rose 6% After Its $11 Billion Apogee Deal: What a $347 Target Means for Investors

AbbVie Stock Rose 6% After Its $11 Billion Apogee Deal: What a $347 Target Means for Investors  TIKR.com

Summary aggregated from TIKR.com's public RSS feed. The full reporting belongs to TIKR.com — please read it on their site.